Yamamoto, Suguru
Karaboyas, Angelo
Komaba, Hirotaka
Taniguchi, Masatomo
Nomura, Takanobu
Bieber, Brian A.
De Sequera, Patricia
Christensson, Anders
Pisoni, Ronald L.
Robinson, Bruce M.
Fukagawa, Masafumi
Article History
Received: 6 July 2018
Accepted: 24 September 2018
First Online: 5 October 2018
Ethics approval and consent to participate
: IRB approval was obtained from E&I West Coast Board on May 23, 2016, IRB # IRB00007807. Written, informed consent was obtained from participants.
: Not applicable.
: S.Y. has received honoraria from Kyowa Hakko Kirin. H.K. has received honoraria, consulting fees, and/or grant/research support from Bayer Yakuhin and Kyowa Hakko Kirin. M.T. has received consulting fees from Kyowa Hakko Kirin. T.N. is an employee of Kyowa Hakko Kirin. M.F. has received honoraria, consulting fees, and/or grant/research support from Astellas Pharma, Bayer Yakuhin, Kyowa Hakko Kirin, Ono Pharmaceutical, and Torii Pharmaceutical. A.K., B.A.B., R.L.P., and B.M.R. are employees for the non-profit research organization Arbor Research Collaborative for Health, which has designed and carries out the Dialysis Outcomes and Practice Patterns Study (DOPPS) Program. Grants are made to Arbor Research Collaborative for Health and not to individual investigators. The remaining authors have no conflicts to report.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.